Skip to main content
SpringerLink
Log in

Selection and Development of Biomarkers for Bladder Cancer

  • Protocol
Tumor Marker Protocols

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 14))

Abstract

Bladder cancer attacked approx 50,500 Americans in 1995 and killed about 11,200 (1). Bladder cancer appears to develop along two mam tracks: a deeply mvasive, high-grade form that rapidly becomes life-threatening, and a much less dangerous low-grade form (2–5). Although low-grade tumors are usually cured readily, by simple resection if detected early or by Bacille Calmette-Guerin (BCG) therapy in the case of multiple tumors, the detection of lowgrade tumors is pressing because approx 15% of patients with these tumors progress to dangerous disease (6) Given this tendency to progress, even though approx 70% of bladder cancers are low grade on inriral diagnosis, the number of deaths caused by bladder cancer is almost equally divided between those with aggressive disease upon presentation and those who progress from lowgrade disease. Thus, the ability to detect a group at high risk for progression, or to detect progression early, is crucial to decreasing the death toll from bladder cancer, particularly if detection could be based on noninvasive techniques that quantitate biochemical changes in exfoliated cells found in urine Conventional cytologic methods have poor sensitivity to low-grade tumors (2,3), though the addition of DNA ploidy by image analysis, which only detects the limited class of low-grade tumors with aberrant ploidy or bladders with field disease, improves the sensitivity 15–20% compared to Papanicolaou cytology (7–9).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Parker S L, Tong T, Bolden S, and Wingo P A (1996) Cancer statistics. Cancer J Clin 46, 5–27

    Article  CAS  Google Scholar 

  2. Farrow G M (1990) Urine cytology in the detection of bladder cancer a critical approach J Occup Med 32, 817–821

    Article  PubMed  CAS  Google Scholar 

  3. Koss L. G (1979) Tumors of the urinary tract and prostate, in Diagnostic Cytology and Its Histologic Basis (Koss L. G., ed.), Lippincott, Philadelphia, PA, pp 749–811

    Google Scholar 

  4. Presti J C, Jr, Reuter V. E, Galan T, Fan W R, and Cordon-Cardo C (1991) Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res 51, 5405–5409.

    PubMed  Google Scholar 

  5. Spruck C H, III, Ohneseit P F, Gonzalez-Zulueta M, Esrig D., Miyao N, Tsai Y C, Lerner S P, Schmutte C, Yang A S, Cote R, Dubeau L, Nichols P. W, Hermann G. G, Steven K, Horn T, Skinner D G, and Jones P A (1994) Two molecular pathways to transitional cell carcinoma of the bladder Cancer Res 54, 784–788

    PubMed  CAS  Google Scholar 

  6. Heney N M, Ahmed S, Flanagan M J, Frable W, Corder M P., Hafermann M. D., and Hawkins I. R. (1983) Superficial bladder cancer· progression and recurrence J Urol 130, 1083–1086.

    PubMed  CAS  Google Scholar 

  7. Bass R. A., Hemstreet G. P., Honker N A., Hurst R. E., and Doggett R S (1987) DNA cytometry and cytology by quantitative fluorescence image analysis in symptomatic bladder cancer pattents Int J Cancer 40, 698–705.

    Article  PubMed  CAS  Google Scholar 

  8. Amberson J. and Laino J (1993) Image cytometric deoxyribonucleic acid analysis of urine specimens as an adjunct to visual cytology in the detection of urothelial cell carcinoma J Urol 149, 42–45

    PubMed  CAS  Google Scholar 

  9. Hemstreet G P, Bonner R B, Hurst R E, and O’Dowd G A (1996) Cytology of Bladder Cancer, in Comprehensive Textbook of Genitourinary Oncology (Vogelzang N J, Scardino P T, Shipley W U, and Coffey D S, eds ), Wilhams and Wilkins, Baltimore, MD, pp 338–350

    Google Scholar 

  10. Weinberg R (1989) Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis Cancer Res 49, 3713–3721

    PubMed  CAS  Google Scholar 

  11. Pienta K, Partin A., and Coffey D S (1989) Cancer as a disease of DNA organization and dynamic cell structure Cancer Res 49, 2525–2532

    PubMed  CAS  Google Scholar 

  12. Tzen G, Estervig D. N., Minoo P., Filipak M., Maercklein P., Hoerl B, and Scott R. (1988) Differentiation, cancer, and anticancer activity. Biochem Cell Biol 66, 478–489

    Article  PubMed  CAS  Google Scholar 

  13. Heldin C, Betscholz C, Claesson-Welsh L, and Westermark B. (1987) Subversion of growth regulatory pathways in malignant transformation. Biochim Biophys Acta 907, 219–244

    PubMed  CAS  Google Scholar 

  14. Couture J and Hansen M (1991) Recessive genes in tumorigenesis Cancer Bull 43, 41–50

    Google Scholar 

  15. Kastan M. B, Onyekwere O, Sidransky D, Vogelstein B, and Craig R W (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51, 6304–6311

    PubMed  CAS  Google Scholar 

  16. Ruoslahti E. and Yamaguchi Y (1991) Proteoglycans as modulators of growth factors Cell 64, 867–869

    Article  PubMed  CAS  Google Scholar 

  17. Nathan C. and Sporn M (1991) Cytokines in context. J Cell Biol 113, 98l–986

    Article  Google Scholar 

  18. Harris C. C (1991) Chemical and physical carcinogenesis: advances and perspectives for the 1990s Cancer Res 51, 5023s–5044s.

    PubMed  CAS  Google Scholar 

  19. Trosko J E, Chang C. C., Madhukar B. V., and Oh S. Y. (1990) Modulators of gap junction function the scientific basis of epigenetic toxicology In Vitro Toxicol 3, 9–26

    CAS  Google Scholar 

  20. Cuthill S. (1994) Cellular epigenetics and the origin of cancer BioEssays 16, 393,394.

    Article  Google Scholar 

  21. Hemstreet G. P, III, Rao J Y, Hurst R. E., Bonner R. B., Jones P. L, Vaidya A. M., Fradet Y, Moon R C, and Kelloff G. J (1992) Intermediate endpoint biomarkers for chemoprevention. J Cell Biochem Suppl. 161, 93–110.

    Article  Google Scholar 

  22. Prehn R T. (1994) Cancers beget mutations versus mutations beget cancers Cancer Res 54, 5296–5300

    PubMed  CAS  Google Scholar 

  23. Rao J. Y., Hemstreet G P., Hurst R. E, Bonner R B, Jones P. L, Min K W, and Fradet Y (1993) Alterations in phenotypic biochemical markers in bladder epithelium during tumortgenesis Proc Natl Acad Sci USA 90, 8287–8291

    Article  PubMed  CAS  Google Scholar 

  24. Norming U., Nyman C, and Tribukait B. (1989) Comparative flow and cytometric deoxyribonucleic acid studies on exophytic tumor and random mucosal biopsies in untreated carcinoma of the bladder J Urol 142, 1442–1447

    PubMed  CAS  Google Scholar 

  25. Vogelstein B, Fearon E., Hamilton S., Kern S, Preisinger A C, Leppert M., et al (1988) Genetic alterations during colorectal tumor development N Engl J Med 319, 525–532

    Article  PubMed  CAS  Google Scholar 

  26. Sidransky D, von Eschenbach A, Tsai Y. C, Jones P, Summerhayes I, Marshall F, Paul M, Green P., Hamilton S R, Frost P, et al (1991) Identification of p53 gene mutations in bladder cancers and urine samples Science 252, 706–709

    Article  PubMed  CAS  Google Scholar 

  27. Sidransky D., Frost P, von Eschenbach A. C, Dyasu R, Preisinger A C, and Vogelstein B (1992) Clonal origin bladder cancer N. Engl J Med 326, 759–761

    Article  Google Scholar 

  28. Pagano F., Pegoraro V, Prayer-Galetti T, Pizzarella M, Milain C, and Garbeglio A (1987) Prognosis of bladder cancer II. The fate of patients with Tlb transitional cell bladder cancer. Eur Urol 13, 305–309

    PubMed  CAS  Google Scholar 

  29. Dalbagin G, Presti J., Reuter V., Fax W R, and Cordon-Cardo C (1993) Genetic alterations in bladder cancer Lancet 342, 469–471

    Article  Google Scholar 

  30. Tsai Y. C., Nichols P. W, Skinner D. G., and Jones P A. (1990) Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer Cancer Res 50, 44–47

    PubMed  CAS  Google Scholar 

  31. Hopman A, Moesker O., Smeets A, Pauwels R, Vooijs G, and Ramaekers F C S (1991) Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization Cancer Res 51, 644–651

    PubMed  CAS  Google Scholar 

  32. Borland R, Brendler C, and Isaacs W B (1992) Molecular biology of bladder cancer Hematol Oncol Clin North Am 6, 31–39

    PubMed  CAS  Google Scholar 

  33. Cairns P., Shaw M. E., and Knowles M. A. (1993) Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9 Oncogene 8, 1083–1085

    PubMed  CAS  Google Scholar 

  34. Linnenbach A J, Pressler L B, Seng B A, Kimmel B S, Tomaszewski J. E, and Malkowicz S B (1993) Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay Human Mol Genet 2, 1407–1411

    Article  CAS  Google Scholar 

  35. Miyao N, Tsai Y C, Lerner S P, Olumi A F, Spruck C. H., III, Gonzalez-Zulueta M, Nichols P. W, Skinner D G., and Jones P. A. (1993) Role of chromosome 9 in human bladder cancer. Cancer Res 53, 4066–4070

    PubMed  CAS  Google Scholar 

  36. Ruppert J. M, Tokino K, and Sidransky D. (1993) Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res. 53, 5093–5095

    PubMed  CAS  Google Scholar 

  37. Keen A. J. and Knowles M. A (1994) Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder Oncogene 9, 2083–2088

    PubMed  CAS  Google Scholar 

  38. Orlow I, Lianes P, Lacombe L, Dalbagni G., Reuter V. E., and Cordon-Cardo C (1994) Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res 54, 2848–2851.

    PubMed  CAS  Google Scholar 

  39. Wheeless L L, Reeder J E, Han R, O’Connell M J, Frank I N, Cockett A T, and Hopman A H (1994) Bladder inrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei Cytometry 17, 319–326

    Article  PubMed  CAS  Google Scholar 

  40. Habuchi T., Devlin J., Elder P. A., and Knowles M. A (1995) Detailed deletion mapping of chromosome 9q in bladder cancer· evidence for two tumour suppressor loci Oncogene 11, 167l–l674.

    Google Scholar 

  41. Sauter G., Moth H., Carroll P., Kerschmann R, Mihatsch M. J, and Waldman F M (1995) Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer Int J Cancer 64, 99–103.

    Article  PubMed  CAS  Google Scholar 

  42. Finn W and Hemstreet G. (1995) Biological Markers in Urinary Toxicology, in National Research Council (Helmstreet G P, ed), National Academy Press, Washington, DC, pp 81–152.

    Google Scholar 

  43. Schatzkin A., Freedman L, Schiffman M., and Dawsey S M (1990) Validation of intermediate end points in cancer research J Nail Cancer Inst 82, 1746–1752

    Article  CAS  Google Scholar 

  44. Schulte P. A., Ringen K, Hemstreet G. P, and Ward E. (1987) Occupational cancer of the urinary tract, in Occupational Cancer and Carcinogenesis (Rauf P B, ed.), Hanley and Belfus, Philadelphia, PA, pp. 85–107

    Google Scholar 

  45. Granados E, de la Torte P, and Palou J (1991) Echography and cystoscopy 2 diagnostic means in bladder tumor (1) [Spanish]. Actas Urol Espanol 15, 540–542

    CAS  Google Scholar 

  46. Parry W. and Hemstreet G. P (1988) Cancer detection by quantitative fluorescence image analysis J Urol 139, 270–274.

    PubMed  CAS  Google Scholar 

  47. Koss L. G and Czerniak B (1992) Image analysis and flow cytometry of tumors of prostate and bladder; with a comment on molecular biology of urothelial tumors Monographs Pathol 34, 112–128

    Google Scholar 

  48. Bonner R. B., Hemstreet G. P., Fradet Y, Rao J. Y., Min K W, and Hurst R E (1993) Bladder cancer risk assessment with quantitative fluorescence image analysts of tumor markers in exfoliated bladder cells. Cancer 72, 246l–2469

    Article  Google Scholar 

  49. Fradet Y, Veltri R, Simard P, Blumenstein B, O’Dowd G, Johnson K, and Miller C. (1996) Improved detection of bladder cancer by immunocytology with monoclonal antibodies M344 and 19A211 Canadian J Ural Suppl. 3, A40.

    Google Scholar 

  50. Devonec M., Darzynkiewicz Z., Kostyrka-Claps M. L, Collste L., Whitmore W. F, Jr., and Melamed M R (1982) Flow cytometry of low stage bladder tumors: correlation with cytologic and cystoscopic diagnosis. Cancer 49, 109–118.

    Article  PubMed  CAS  Google Scholar 

  51. Bi W, Rao J., Hemstreet G P, Fang P., Asal N. R, Zang M, Min K. W., Ma Z., Lee E., Li G, Hurst R E, Bonner R B., Weng Y, Fradet Y, and Yin S. (1993) Field molecular epidemiology Feasibility of monitoring for the malignant bladder cell phenotype in a benzidine-exposed occupational cohort J. Occup Med 35, 20–27.

    PubMed  CAS  Google Scholar 

  52. Wheeless L. L., Badalament R. A, DeVere White R W., Fradet Y, and Tribukait B. (1993) Consensus review of the clinical utility of DNA cytometry in bladder cancer Cytometry 14, 478–481

    Article  PubMed  CAS  Google Scholar 

  53. Rao J. Y., Hurst R E, Bales W. D, Jones P L, Bass R. A, Archer L T, and Hemstreet G. P. (1990) Cellular F-actin levels as a marker for cellular transformation· relationship to cell division and differentration Cancer Res 50, 2215–2220.

    PubMed  CAS  Google Scholar 

  54. Rao J Y, Hemstreet G P, Hurst R E, Bonner R. B., Min K. W., and Jones P. L (1991) Cellular F-actin levels as a marker for cellular transformation: correlation with bladder cancer risk Cancer Res 51, 2762–2767

    PubMed  CAS  Google Scholar 

  55. Rao J Y, Bonner R. B, Hurst R E, Qiu W R, Reznikoff C A, and Hemstreet G. P (1996) Quantitative changes in cytoskeletal and nuclear actin levels during cellular transformation Int J Cancer 70, 423–429

    Article  Google Scholar 

  56. Hemstreet G P, Rao J Y., Hurst R. E, Bonner R B, Waliszewski P, Grossman H. B, Liebert M., and Bane B L. (1996) G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials. J Cell Biochem Suppl, 255, 197–204

    Article  Google Scholar 

  57. Carter H, Amberson J, Bander N, Badalament R. A, Gorelick J, Vaughan E, and Whitmore A. (1987) Newer diagnostic techniques for bladder cancer Urol Clin North Am 14, 763–769.

    PubMed  CAS  Google Scholar 

  58. Nakamura N., Hurst R E, West S S, Menter J M, Golden J F, Corliss D A, and Jones D D (1980) Biophysical cytochemical investigations of intracellular heparin in neoplastic mast cells J Histochem Cytochem 28, 223–230

    Article  PubMed  CAS  Google Scholar 

  59. West S S., Hemstreet G. P, Hurst R E., Bass R A., Doggett R S, and Schulte P A. (1987) Detection of DNA aneuploidy by quantitative fluorescence image analysis potential in screening for occupational bladder cancer, in Biological Monitoring of Exposure to Chemicals (Dillon K and Ho M., eds), Wiley, New York, pp 327–341.

    Google Scholar 

  60. McGowan P, Hurst R E, Bass R E., Hemstreet G P., and Postier R. (1988) Equilibrium binding of Hoechst 33258 and Hoechst 33342 fluorochromes with rat colorectal cells J Histochem Cytochem 36, 757–762

    Article  PubMed  CAS  Google Scholar 

  61. Jones P L, O’Hare C, Bass R. A, Rao J Y., Hemstreet G P, and Hurst R E. (1990) Quantitative immunofluorescence, anti-ras p21 antibody specificity and cellular oncoprotem levels Biochem Biophys Res. Commun 167, 464–470

    Article  PubMed  CAS  Google Scholar 

  62. Fidler I. J (1991) The biology of human cancer metastasis Acta Oncologica 30, 669–675

    Google Scholar 

  63. Aznavoorian S, Murphy A N, Steller-Stevenson W G, and Liotta L A. (1993) Molecular aspects of tumor cell invasion and metastasis. Cancer 71, 1368–1383

    Article  PubMed  CAS  Google Scholar 

  64. Ichikawa T, Nihei N, Kuramochi J., Kawana Y, Killary A M, Rinker-Schaeffer C W, Barrett J. C., Isaacs J. T., Kugoh H., Oshimura M., and Shimazaki J. (1996) Metastasis suppressor genes for prostate cancer Prostate 6, 31–35

    Article  CAS  Google Scholar 

  65. Kerbel R. (1989) Towards an understanding of the molecular basis of the metastatic phenotype. Inv. Metast. 9, 329–337.

    CAS  Google Scholar 

  66. Klienman H. K and Kibbey M C (1991) Basement membrane regulation of tumor growth and metastasis J NIH Res. 3, 63,64

    Google Scholar 

  67. Lu C and Kerbel R S. (1994) Cytokines, growth factors and the loss of negative growth controls in the progression of human cutaneous malignant melanoma Current Opinion Oneol 6, 212–220

    Article  CAS  Google Scholar 

  68. Raz A. (1988) Actin organizatron, cell motility, and metastasis. Adv Exp Med Biol 233, 227–233

    PubMed  CAS  Google Scholar 

  69. vanden Hooff A. (1991) The role of stromal cells in tumor metastasis a new link. Cancer Cells 3, 186,187.

    PubMed  Google Scholar 

  70. Ware J. L (1993) Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metast Rev 12, 287–301

    Article  CAS  Google Scholar 

  71. Yokozaki H and Tahara E. (1994) Metastasis-related genes [Japanese] Gan to Kagaku Ryoho [Japanese Journal of Cancer and Chemotherapy], 21, 2541–2548.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Urology, Pathology, and Environmental Health Sciences, University of Oklahoma Health Science Center, Oklahoma City, OK

    George P. Hemstreet III

  2. Departments of Urology, Biochemistry and Molecular Biology, and Environmental Health Sciences, University of Oklahoma Health Science Center, Oklahoma City, OK

    Robert E. Hurst

  3. Department of Urology, University of Oklahoma Health Science Center, Oklahoma City, OK

    Rebecca B. Bonner

Authors
  1. George P. Hemstreet III
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert E. Hurst
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rebecca B. Bonner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. AMC Cancer Research Center, Denver, CO

    Margaret Hanausek  & Zbigniew Walaszek  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Humana Press Inc, Totowa, NJ

About this protocol

Cite this protocol

Hemstreet, G.P., Hurst, R.E., Bonner, R.B. (1998). Selection and Development of Biomarkers for Bladder Cancer. In: Hanausek, M., Walaszek, Z. (eds) Tumor Marker Protocols. Methods in Molecular Medicine™, vol 14. Springer, Totowa, NJ. https://doi.org/10.1385/0-89603-380-5:37

Download citation

  • DOI: https://doi.org/10.1385/0-89603-380-5:37

  • Publisher Name: Springer, Totowa, NJ

  • Print ISBN: 978-0-89603-380-1

  • Online ISBN: 978-1-59259-598-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation